- call +1-201-465-4211
- email sales@mrinsights.biz
Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases.
Scope of the Report:
This report focuses on the Cardiovascular Implants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals. Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.
The worldwide market for Cardiovascular Implants is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
Boston Scientific
Medtronic
St. Jude Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Coronary Stents
Peripheral Stents
Heart Valves
Implanted Cardiac Pacemakers
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT) Device
Market Segment by Applications, can be divided into
Minimally Invasive Heart Surgery
Heart Valve Repair or Replacement
Cardiac Resynchronization Therapy (CRT)
Open Heart Surgery
Others
There are 15 Chapters to deeply display the global Cardiovascular Implants market.
Chapter 1, to describe Cardiovascular Implants Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiovascular Implants, with sales, revenue, and price of Cardiovascular Implants, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiovascular Implants, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cardiovascular Implants market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cardiovascular Implants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cardiovascular Implants Introduction
1.2 Market Analysis by Type
1.2.1 Coronary Stents
1.2.2 Peripheral Stents
1.2.3 Heart Valves
1.2.4 Implanted Cardiac Pacemakers
1.2.5 Implantable Cardioverter Defibrillator
1.2.6 Cardiac Resynchronization Therapy (CRT) Device
1.3 Market Analysis by Applications
1.3.1 Minimally Invasive Heart Surgery
1.3.2 Heart Valve Repair or Replacement
1.3.3 Cardiac Resynchronization Therapy (CRT)
1.3.4 Open Heart Surgery
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Cardiovascular Implants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Cardiovascular Implants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific
2.2.1 Business Overview
2.2.2 Cardiovascular Implants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Cardiovascular Implants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medtronic
2.3.1 Business Overview
2.3.2 Cardiovascular Implants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Cardiovascular Implants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 St. Jude Medical
2.4.1 Business Overview
2.4.2 Cardiovascular Implants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 St. Jude Medical Cardiovascular Implants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cardiovascular Implants Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cardiovascular Implants Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cardiovascular Implants Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cardiovascular Implants Manufacturer Market Share in 2017
3.3.2 Top 6 Cardiovascular Implants Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cardiovascular Implants Market Analysis by Regions
4.1 Global Cardiovascular Implants Sales, Revenue and Market Share by Regions
4.1.1 Global Cardiovascular Implants Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cardiovascular Implants Revenue and Market Share by Regions (2013-2018)
4.2 North America Cardiovascular Implants Sales and Growth Rate (2013-2018)
4.3 Europe Cardiovascular Implants Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cardiovascular Implants Sales and Growth Rate (2013-2018)
4.5 South America Cardiovascular Implants Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cardiovascular Implants Sales and Growth Rate (2013-2018)
5 North America Cardiovascular Implants by Countries
5.1 North America Cardiovascular Implants Sales, Revenue and Market Share by Countries
5.1.1 North America Cardiovascular Implants Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cardiovascular Implants Revenue and Market Share by Countries (2013-2018)
5.2 United States Cardiovascular Implants Sales and Growth Rate (2013-2018)
5.3 Canada Cardiovascular Implants Sales and Growth Rate (2013-2018)
5.4 Mexico Cardiovascular Implants Sales and Growth Rate (2013-2018)
6 Europe Cardiovascular Implants by Countries
6.1 Europe Cardiovascular Implants Sales, Revenue and Market Share by Countries
6.1.1 Europe Cardiovascular Implants Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cardiovascular Implants Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cardiovascular Implants Sales and Growth Rate (2013-2018)
6.3 UK Cardiovascular Implants Sales and Growth Rate (2013-2018)
6.4 France Cardiovascular Implants Sales and Growth Rate (2013-2018)
6.5 Russia Cardiovascular Implants Sales and Growth Rate (2013-2018)
6.6 Italy Cardiovascular Implants Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cardiovascular Implants by Countries
7.1 Asia-Pacific Cardiovascular Implants Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cardiovascular Implants Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cardiovascular Implants Revenue and Market Share by Countries (2013-2018)
7.2 China Cardiovascular Implants Sales and Growth Rate (2013-2018)
7.3 Japan Cardiovascular Implants Sales and Growth Rate (2013-2018)
7.4 Korea Cardiovascular Implants Sales and Growth Rate (2013-2018)
7.5 India Cardiovascular Implants Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cardiovascular Implants Sales and Growth Rate (2013-2018)
8 South America Cardiovascular Implants by Countries
8.1 South America Cardiovascular Implants Sales, Revenue and Market Share by Countries
8.1.1 South America Cardiovascular Implants Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cardiovascular Implants Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cardiovascular Implants Sales and Growth Rate (2013-2018)
8.3 Argentina Cardiovascular Implants Sales and Growth Rate (2013-2018)
8.4 Colombia Cardiovascular Implants Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cardiovascular Implants by Countries
9.1 Middle East and Africa Cardiovascular Implants Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cardiovascular Implants Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cardiovascular Implants Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cardiovascular Implants Sales and Growth Rate (2013-2018)
9.3 UAE Cardiovascular Implants Sales and Growth Rate (2013-2018)
9.4 Egypt Cardiovascular Implants Sales and Growth Rate (2013-2018)
9.5 Nigeria Cardiovascular Implants Sales and Growth Rate (2013-2018)
9.6 South Africa Cardiovascular Implants Sales and Growth Rate (2013-2018)
10 Global Cardiovascular Implants Market Segment by Type
10.1 Global Cardiovascular Implants Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cardiovascular Implants Sales and Market Share by Type (2013-2018)
10.1.2 Global Cardiovascular Implants Revenue and Market Share by Type (2013-2018)
10.2 Coronary Stents Sales Growth and Price
10.2.1 Global Coronary Stents Sales Growth (2013-2018)
10.2.2 Global Coronary Stents Price (2013-2018)
10.3 Peripheral Stents Sales Growth and Price
10.3.1 Global Peripheral Stents Sales Growth (2013-2018)
10.3.2 Global Peripheral Stents Price (2013-2018)
10.4 Heart Valves Sales Growth and Price
10.4.1 Global Heart Valves Sales Growth (2013-2018)
10.4.2 Global Heart Valves Price (2013-2018)
10.5 Implanted Cardiac Pacemakers Sales Growth and Price
10.5.1 Global Implanted Cardiac Pacemakers Sales Growth (2013-2018)
10.5.2 Global Implanted Cardiac Pacemakers Price (2013-2018)
10.6 Implantable Cardioverter Defibrillator Sales Growth and Price
10.6.1 Global Implantable Cardioverter Defibrillator Sales Growth (2013-2018)
10.6.2 Global Implantable Cardioverter Defibrillator Price (2013-2018)
10.7 Cardiac Resynchronization Therapy (CRT) Device Sales Growth and Price
10.7.1 Global Cardiac Resynchronization Therapy (CRT) Device Sales Growth (2013-2018)
10.7.2 Global Cardiac Resynchronization Therapy (CRT) Device Price (2013-2018)
11 Global Cardiovascular Implants Market Segment by Application
11.1 Global Cardiovascular Implants Sales Market Share by Application (2013-2018)
11.2 Minimally Invasive Heart Surgery Sales Growth (2013-2018)
11.3 Heart Valve Repair or Replacement Sales Growth (2013-2018)
11.4 Cardiac Resynchronization Therapy (CRT) Sales Growth (2013-2018)
11.5 Open Heart Surgery Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Cardiovascular Implants Market Forecast (2018-2023)
12.1 Global Cardiovascular Implants Sales, Revenue and Growth Rate (2018-2023)
12.2 Cardiovascular Implants Market Forecast by Regions (2018-2023)
12.2.1 North America Cardiovascular Implants Market Forecast (2018-2023)
12.2.2 Europe Cardiovascular Implants Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cardiovascular Implants Market Forecast (2018-2023)
12.2.4 South America Cardiovascular Implants Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cardiovascular Implants Market Forecast (2018-2023)
12.3 Cardiovascular Implants Market Forecast by Type (2018-2023)
12.3.1 Global Cardiovascular Implants Sales Forecast by Type (2018-2023)
12.3.2 Global Cardiovascular Implants Market Share Forecast by Type (2018-2023)
12.4 Cardiovascular Implants Market Forecast by Application (2018-2023)
12.4.1 Global Cardiovascular Implants Sales Forecast by Application (2018-2023)
12.4.2 Global Cardiovascular Implants Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cardiovascular Implants Picture
Table Product Specifications of Cardiovascular Implants
Figure Global Sales Market Share of Cardiovascular Implants by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
